Todd Mc Collough
About Todd Mc Collough
Todd Mc Collough is a Senior Territory Business Manager in Dermatology at Bristol Myers Squibb with extensive experience in the pharmaceutical and biotechnology industries.
Current Role at Bristol Myers Squibb
Todd Mc Collough currently serves as a Senior Territory Business Manager specializing in Dermatology at Bristol Myers Squibb. In this role, he leverages his expertise in biologics and dermatology to drive business growth. His responsibilities include managing territory-specific business operations and forming strategic partnerships within the dermatology field.
Previous Experience in Dermatological Sales
Before joining Bristol Myers Squibb, Todd Mc Collough worked as a Senior Dermatological Sales Professional at Galderma from 2021 to 2022 in Seattle, Washington. During his 11-month tenure, he focused on enhancing sales strategies and customer relationships within the dermatological sector.
Professional Background in Respiratory and Specialty Sales
Prior to his role at Galderma, Todd Mc Collough was an Executive Clinical Specialist in Respiratory at Novartis from 2018 to 2020 in the Greater Seattle Area. His expertise in specialty sales and biologics was utilized to drive sales performance in the respiratory field. Additionally, he held the position of Key Account Manager, Specialty Sales at Turing Pharmaceuticals AG, and Vyera Pharmaceuticals, LLC from 2015 to 2018, covering regions like Seattle, Los Angeles, and Sacramento.
Long-Term Career at Bristol Myers Squibb and Other Companies
Todd's extensive career also includes an 18-year stint as an Executive Territory Business Manager at Bristol Myers Squibb spanning Seattle, Washington, and Alaska, from 1997 to 2015. He initially started his career as a Biological Product Specialist at Connaught Laboratories and a Territory Sales Manager at Medi USA.
Educational Background in Economics
Todd Mc Collough holds a Bachelor of Arts (B.A.) in Economics from the University of Washington, which he completed between 1982 and 1987. His academic background in economics provided a strong foundation for his subsequent career in the pharmaceutical and biotechnology industries.